Currently, the share price for Eris Lifesciences Ltd. is delayed. Login to view live prices.
Eris Lifesciences Ltd.
0.00 (0.00%) 1D
- Prev. Close944.95
- Upper Circuit1,133.90
- Lower Circuit756.00
Analyst Recommendations For Eris Lifesciences Ltd.
As recommended by 3 analysts
Eris Lifesciences Ltd.'s Info & Management
ERIS Lifesciences is engaged in the manufacturing and Marketing of Pharmaceutical Products.
- Managing DirectorAmit Bakshi
- Executive Director,Whole Time Director,Chief Operating OfficerKrishnakumar Vaidyanathan
- Chief Financial OfficerSachin Shah
- Vice PresidentAlok Mahajan
- Vice PresidentSantosh Danavale
- Senior Vice PresidentDeepak Kapoor
FAQs on Eris Lifesciences Ltd.
What is the share price of Eris Lifesciences Ltd.?
Eris Lifesciences Ltd. share price is ₹947.65 as of November 30, 2023, 10:36 AM. Share prices change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the market cap of Eris Lifesciences Ltd.?
Market cap is calculated by multiplying the company's share price with the total outstanding shares. The market cap of Eris Lifesciences Ltd. is ₹12,854 Cr as of November 30, 2023.
What is the PE ratio of Eris Lifesciences Ltd.?
The PE ratio of Eris Lifesciences Ltd. is 33.30 as of November 30, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).
What is the PB ratio of Eris Lifesciences Ltd.?
The trailing twelve month (TTM) PB ratio of Eris Lifesciences Ltd. is 5.80 as of November 30, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Eris Lifesciences Ltd.?
Upper Circuit is ₹1,133.9. Lower Circuit is ₹756.
What is the ROE of Eris Lifesciences Ltd.?
Eris Lifesciences Ltd. reported an ROE of 17.40% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Eris Lifesciences Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Eris Lifesciences Ltd., Promoter held 54.9%, the FII held 13.2%, DII held 14.5% and the public held 17.4% of the total shares.
How to buy Eris Lifesciences Ltd. Share?
What is the fair value of Eris Lifesciences Ltd.?
Fair value in investing refers to the estimated potential price of the business. The market (or exchange) is expected to determine the fair value of listed companies by the way of demand and supply. To determine the fair value of Eris Lifesciences Ltd. as per market, look at the current bid and ask prices during the trading hours.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.